Case series of dermatologic events associated with the insulin-like growth factor receptor 1 inhibitor cixutumumab.
暂无分享,去创建一个
Helen X. Chen | M. Lacouture | G. Abou-Alfa | R. Maki | D. Rathkopf | M. Daher | M. Keohan | B. Gansukh
[1] P. Bougnères,et al. Near normalization of adult height and body proportions by growth hormone in pycnodysostosis. , 2010, The Journal of clinical endocrinology and metabolism.
[2] J. D. de Fijter,et al. mTOR inhibitor‐associated dermatologic and mucosal problems , 2010, Clinical transplantation.
[3] Toru Takahashi,et al. Incidence of koilonychia and atrophy of the lingual papillae in a patient with iron-deficiency anemia , 2010, International journal of hematology.
[4] A. Gualberto,et al. Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions , 2009, Oncogene.
[5] Linda Koch,et al. Epidermal insulin/IGF‐1 signalling control interfollicular morphogenesis and proliferative potential through Rac activation , 2008, The EMBO journal.
[6] J. Bourhis,et al. Mechanisms of Disease: signaling of the insulin-like growth factor 1 receptor pathway—therapeutic perspectives in cancer , 2007, Nature Clinical Practice Oncology.
[7] D. Ludwig,et al. IMC-A12, a Human IgG1 Monoclonal Antibody to the Insulin-Like Growth Factor I Receptor , 2007, Clinical Cancer Research.
[8] L. Stead,et al. Images in emergency medicine. Koilonychia, or spoon-shaped nails nails, is generally associated with iron-deficiency anemia. , 2007, Annals of emergency medicine.
[9] Yan Wang,et al. Inhibition of the IGF-I receptor for treatment of cancer. Kinase inhibitors and monoclonal antibodies as alternative approaches. , 2007, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[10] J. Riedemann,et al. IGF1R signalling and its inhibition. , 2006, Endocrine-related cancer.
[11] Derek LeRoith,et al. Insulin-Like Growth Factor 1 Receptor Signaling Regulates Skin Development and Inhibits Skin Keratinocyte Differentiation , 2006, Molecular and Cellular Biology.
[12] Zee Upton,et al. Insulin-like growth factors (IGF) and IGF-binding proteins bound to vitronectin enhance keratinocyte protein synthesis and migration. , 2004, The Journal of investigative dermatology.
[13] E. Bohula,et al. Targeting the type 1 insulin-like growth factor receptor as anti-cancer treatment , 2003, Anti-cancer drugs.
[14] A. Soliman,et al. Pycnodysostosis: clinical, radiologic, and endocrine evaluation and linear growth after growth hormone therapy. , 2001, Metabolism: clinical and experimental.
[15] A. Boulton,et al. Lack of insulin‐like growth factor 1 (IGF1) in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers , 2000, The Journal of pathology.
[16] James T. Elder,et al. Maintenance of human skin in organ culture: role for insulin-like growth factor-1 receptor and epidermal growth factor receptor , 1999, Archives of Dermatological Research.
[17] O. Stone. Clubbing and koilonychia. , 1985, Dermatologic clinics.